Study of Safety and Immunogenicity of BVRS-GamVac
Conditions: MERS (Middle East Respiratory Syndrome); MERS Interventions: Biological: BVRS-GamVac; Other: placebo Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials